biguanides has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hébert, A | 1 |
| Parisotto, M | 1 |
| Rowell, MC | 1 |
| Doré, A | 1 |
| Fernandez Ruiz, A | 1 |
| Lefrançois, G | 1 |
| Kalegari, P | 1 |
| Ferbeyre, G | 1 |
| Schmitzer, AR | 1 |
1 other study available for biguanides and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth.
Topics: AMP-Activated Protein Kinases; Animals; Biguanides; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; | 2021 |